Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,276.00    20.00 (1.59%)
Bid:
1,284.00
Ask:
1,292.00
Spread: 8.00 (0.623%)
Market Cap: £584.74m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

AGM Statement & First Quarter Update

15 Sep 2020 07:00

RNS Number : 9637Y
Cohort PLC
15 September 2020
 

One Waterside Drive

Arlington Business Park

Reading

Berks

RG7 4SW

 

15 September 2020

 

 

 

COHORT PLC

("Cohort" or "the Group")

AGM STATEMENT & FIRST QUARTER UPDATE

 

 

Cohort, the independent technology group, is today holding its Annual General Meeting (AGM) and accordingly issues the following AGM Statement and first quarter update:

 

Cohort continued to make good progress in its financial year ended 30 April 2020, achieving a record adjusted operating profit despite the impact of COVID-19 restrictions in the final two months. A full year contribution from Chess, a record performance at MASS and improvement at EID offset weaker trading at MCL and SEA. Following the lifting of lockdown, we have successfully completed a phased process of returning colleagues safely to work and the majority are now back on site on a part time or regular basis.

 

As expected, the restrictions on international travel continue to constrain our ability to develop new export opportunities, which generated over 30% of Cohort's revenues in 2019/20. Nevertheless, the Group entered the 2020/21 financial year with a substantial long-term order book and a strong pipeline of order prospects, and we have continued to win new business since we reported the 2020 final results in July. At 31 August 2020, the Group's order book stood at £210.0m, compared to £183.3m at our 30 April 2020 financial year end. This underpins approximately 83% (or £113m) of the new financial year's consensus forecast revenue, compared to 76% at the same time last year.

 

Cohort remains soundly financed: net debt at 31 August 2020 stood at £1.4m, compared to £4.7m at 30 April 2020. The Group's cash and readily available credit was just over £38m at 31 August 2020 providing significant financing headroom for current anticipated commitments, including the completion of the transaction to acquire Wärtsilä ELAC Nautik ("ELAC") announced on 12 December 2019. The acquisition of ELAC remains subject to approval by the German Federal Government. This process has been delayed by COVID-19 and other factors, but a meeting is now planned for later this month and we expect to have a clearer idea of the completion timetable after that.

 

We continue to expect that our trading performance for 2020/21 financial year will be in line with that achieved in the year ended 30 April 2020, as indicated at the time of the final results announcement in July. We expect net debt to remain flat for the year, after taking account of the acquisition of ELAC.

 

In the longer term, the Group continues to expect to return to growth, as it recovers the orders and revenue delayed due to COVID-19, whilst benefiting from the acquisition of ELAC.

 

Ends

 

For further information, please contact:

 

Cohort plc

0118 909 0390

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director and Company Secretary

Investec Bank plc

020 7597 5970

Daniel Adams / Chris Baird

MHP Communications

020 3128 8100

Reg Hoare / Pete Lambie

 

 

NOTES TO EDITORS

 

Cohort plc (www.cohortplc.com) is the parent company of five innovative, agile and responsive businesses based in the UK and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

Chess Technologies, through its operating businesses Chess Dynamics and Vision4ce, offers electro-optical and electro-mechanical systems to the defence and security markets. It was acquired by Cohort plc in December 2018. www.chess-dynamics.com & www.vision4ce.com

 

EID designs and manufactures advanced communications systems for the defence and security markets. Cohort acquired a majority stake in June 2016. www.eid.pt

 

MASS is a specialist data technology company serving the defence and security markets, focused on electronic warfare, digital services and training support. Acquired by Cohort in August 2006. www.mass.co.uk

 

MCL designs, sources and supports advanced electronic and surveillance technology for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

 

SEA delivers products and services into the defence, transport and offshore energy markets alongside performing specialist research, training and product support. Acquired by Cohort in October 2007. www.sea.co.uk

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has headquarters in Reading, Berkshire and employs in total around 900 core staff there and at its other operating company sites across the UK and in Portugal.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMGPURUBUPUPGC
Date   Source Headline
11th Nov 20095:57 pmRNSOptions Exercise
2nd Nov 20093:43 pmRNSTotal Voting Rights
29th Oct 20097:00 amRNSSEA SIGNS ?5m TWO-YEAR SPACE EXPLORATION CONTRACT
21st Oct 20098:23 amRNSOption Exercise
1st Oct 20099:38 amRNSTotal Voting Rights
18th Sep 20092:18 pmRNSOption Exercise
7th Sep 20097:00 amRNSSEA chosen as preferred bidder on ASTUTE programme
1st Sep 20095:04 pmRNSOption Exercise
1st Sep 200911:01 amRNSTotal Voting Rights
24th Aug 20093:35 pmRNSGrant of Options
21st Aug 20095:27 pmRNSOptions Exercises
3rd Aug 20094:08 pmRNSTotal Voting Rights
22nd Jul 20094:51 pmRNSExercise of Options
22nd Jul 20097:00 amRNSMass signs ?13m seven year BSF contract
1st Jul 20099:23 amRNSTotal Voting Rights
25th Jun 20097:00 amRNSBoard Change
25th Jun 20097:00 amRNSFinal Results
19th Jun 20092:28 pmRNSTotal Voting Rights
1st Jun 20099:46 amRNSTotal Voting Rights
22nd May 20099:00 amRNSHolding(s) in Company
13th May 20095:31 pmRNSAdditional Listing
5th May 20093:01 pmRNSTotal Voting Rights
5th May 20097:00 amRNSBoard Changes
7th Apr 20097:00 amRNSMass selected as preferred bidder on BSF project
1st Apr 200911:12 amRNSAdditional Listing
31st Mar 200911:15 amRNSTotal Voting Rights
26th Mar 200912:35 pmRNSAdditional Listing
9th Jan 20095:27 pmRNSDirector/PDMR Shareholding
19th Dec 20087:00 amRNSPosting of Interim Report to Shareholders
11th Dec 20087:00 amRNSHalf Yearly Report
1st Dec 20082:12 pmRNSTotal Voting Rights
26th Nov 20084:59 pmRNSAdditional Listing
12th Nov 20087:00 amRNSSEA secures ?5m UK and overseas orders
15th Sep 20081:42 pmRNSHolding(s) in Company
31st Jul 200811:50 amRNSTotal Voting Rights
29th Jul 200810:19 amRNSGrant of options
16th Jul 200811:21 amRNSAdditional Listing
26th Jun 20087:00 amRNSFinal Results
12th May 20086:00 amRNSContract Win
7th Apr 20085:22 pmRNSDirector's Shareholding
3rd Mar 20087:01 amRNSRe Contract
21st Feb 200811:26 amRNSHolding(s) in Company
21st Feb 20087:01 amRNSRe Contract
1st Feb 200811:51 amRNSTotal Voting Rights
15th Jan 20087:00 amRNSSEA awarded contracts
2nd Jan 20085:47 pmRNSAdditional Listing
13th Dec 20077:01 amRNSInterim Results
30th Nov 200710:21 amRNSTotal Voting Rights
13th Nov 20071:20 pmRNSOffer Update
7th Nov 20075:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.